{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T08:53:01Z","timestamp":1781513581968,"version":"3.54.1"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T00:00:00Z","timestamp":1774051200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T00:00:00Z","timestamp":1774051200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1038\/s41380-026-03544-0","type":"journal-article","created":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T09:27:53Z","timestamp":1774085273000},"page":"4154-4163","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Identifying genetic contributions of 6q21 loci and PPAR pathway to antipsychotic-induced metabolic syndrome: a Sex-Stratified Multi-Omics study"],"prefix":"10.1038","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3097-3797","authenticated-orcid":false,"given":"Guorui","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8096-3568","authenticated-orcid":false,"given":"Yaoyao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1922-6686","authenticated-orcid":false,"given":"Zhe","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3722-3713","authenticated-orcid":false,"given":"Zhewei","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0474-1135","authenticated-orcid":false,"given":"Yuyanan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyuan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1919-2425","authenticated-orcid":false,"given":"Jing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1065-8597","authenticated-orcid":false,"given":"Xiaoyang","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunqing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingrui","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1201-8465","authenticated-orcid":false,"given":"Weihua","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,21]]},"reference":[{"key":"3544_CR1","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/S0140-6736(21)01730-X","volume":"399","author":"S Jauhar","year":"2022","unstructured":"Jauhar S, Johnstone M, McKenna PJ. Schizophrenia. Lancet. 2022;399:473\u201386.","journal-title":"Lancet"},{"key":"3544_CR2","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1093\/schbul\/sbr148","volume":"39","author":"AJ Mitchell","year":"2013","unstructured":"Mitchell AJ, Vancampfort D, Sweers K, van Winkel R, Yu W, De Hert M. Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders-a systematic review and meta-analysis. Schizophr Bull. 2013;39:306\u201318.","journal-title":"Schizophr Bull"},{"key":"3544_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/j.2051-5545.2009.tb00199.x","volume":"8","author":"M De Hert","year":"2009","unstructured":"De Hert M, Schreurs V, Vancampfort D, van Winkel R. Metabolic syndrome in people with schizophrenia: a review. World Psychiatry. 2009;8:15\u201322.","journal-title":"World Psychiatry"},{"key":"3544_CR4","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","volume":"285","author":"Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults","year":"2001","unstructured":"Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of The National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). Jama. 2001;285:2486\u201397.","journal-title":"Jama"},{"key":"3544_CR5","doi-asserted-by":"publisher","first-page":"696","DOI":"10.5498\/wjp.v11.i10.696","volume":"11","author":"SC Chang","year":"2021","unstructured":"Chang SC, Goh KK, Lu ML. Metabolic disturbances associated with antipsychotic drug treatment in patients with schizophrenia: state-of-the-art and future perspectives. World J Psychiatry. 2021;11:696\u2013710.","journal-title":"World J Psychiatry"},{"key":"3544_CR6","doi-asserted-by":"publisher","first-page":"91","DOI":"10.5694\/mja16.00650","volume":"206","author":"L Kritharides","year":"2017","unstructured":"Kritharides L, Chow V, Lambert TJ. Cardiovascular disease in patients with schizophrenia. Med J Aust. 2017;206:91\u201395.","journal-title":"Med J Aust"},{"key":"3544_CR7","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1007\/s40200-022-01009-z","volume":"21","author":"S Rana","year":"2022","unstructured":"Rana S, Ali S, Wani HA, Mushtaq QD, Sharma S, Rehman MU. Metabolic syndrome and underlying genetic determinants-a systematic review. J Diabetes Metab Disord. 2022;21:1095\u2013104.","journal-title":"J Diabetes Metab Disord"},{"key":"3544_CR8","doi-asserted-by":"publisher","first-page":"467","DOI":"10.3109\/15622975.2016.1165865","volume":"17","author":"L Yang","year":"2016","unstructured":"Yang L, Chen J, Li Y, Wang Y, Liang S, Shi Y, et al. Association between SCAP and SREBF1 gene polymorphisms and metabolic syndrome in schizophrenia patients treated with atypical antipsychotics. World J Biol Psychiatry. 2016;17:467\u201374.","journal-title":"World J Biol Psychiatry"},{"key":"3544_CR9","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1111\/jphp.12892","volume":"70","author":"A Puangpetch","year":"2018","unstructured":"Puangpetch A, Unaharassamee W, Jiratjintana N, Koomdee N, Sukasem C. Genetic polymorphisms of HTR2C, LEP and LEPR on metabolic syndromes in patients treated with atypical antipsychotic drugs. J Pharm Pharmacol. 2018;70:536\u201342.","journal-title":"J Pharm Pharmacol"},{"key":"3544_CR10","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1002\/phar.70041","volume":"45","author":"NE Rouby","year":"2025","unstructured":"Rouby NE, Owusu-Obeng A, Preuss M, Lee S, Shi M, Lape M, et al. Genome-wide associations with metabolic syndrome among UK Biobank participants reporting use of second-generation antipsychotics. Pharmacotherapy. 2025;45:476\u201385.","journal-title":"Pharmacotherapy"},{"key":"3544_CR11","doi-asserted-by":"publisher","first-page":"5195","DOI":"10.1038\/s41380-022-01759-5","volume":"27","author":"W Zhou","year":"2022","unstructured":"Zhou W, Sun J, Huai C, Liu Y, Chen L, Yi Z, et al. Multi-omics analysis identifies rare variation in leptin\/PPAR gene sets and hypermethylation of ABCG1 contribute to antipsychotics-induced metabolic syndromes. Mol Psychiatry. 2022;27:5195\u2013205.","journal-title":"Mol Psychiatry"},{"key":"3544_CR12","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/ng1726","volume":"38","author":"LA Weiss","year":"2006","unstructured":"Weiss LA, Pan L, Abney M, Ober C. The sex-specific genetic architecture of quantitative traits in humans. Nat Genet. 2006;38:218\u201322.","journal-title":"Nat Genet"},{"key":"3544_CR13","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/s41392-024-01929-7","volume":"9","author":"Y Shi","year":"2024","unstructured":"Shi Y, Ma J, Li S, Liu C, Liu Y, Chen J, et al. Sex difference in human diseases: mechanistic insights and clinical implications. Signal Transduct Target Ther. 2024;9:238.","journal-title":"Signal Transduct Target Ther"},{"key":"3544_CR14","doi-asserted-by":"publisher","first-page":"e11961","DOI":"10.1371\/journal.pone.0011961","volume":"5","author":"D Zabaneh","year":"2010","unstructured":"Zabaneh D, Balding DJ. A genome-wide association study of the metabolic syndrome in Indian Asian men. PLoS One. 2010;5:e11961.","journal-title":"PLoS One"},{"key":"3544_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12881-019-0830-y","volume":"20","author":"S Kong","year":"2019","unstructured":"Kong S, Cho YS. Identification of female-specific genetic variants for metabolic syndrome and its component traits to improve the prediction of metabolic syndrome in females. BMC Med Genet. 2019;20:99.","journal-title":"BMC Med Genet"},{"key":"3544_CR16","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s40263-024-01089-w","volume":"38","author":"M Galbally","year":"2024","unstructured":"Galbally M, Wynter K, Siskind D, Correll CU, Northwood K, Every-Palmer S. Sex differences between female and male individuals in antipsychotic efficacy and adverse effects in the treatment of schizophrenia. CNS Drugs. 2024;38:559\u201370.","journal-title":"CNS Drugs"},{"key":"3544_CR17","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/wps.21155","volume":"23","author":"IE Sommer","year":"2024","unstructured":"Sommer IE, Brand BA, Stuijt CCM, Touw DJ. Sex differences need to be considered when treating women with psychotropic drugs. World Psychiatry. 2024;23:151\u20132.","journal-title":"World Psychiatry"},{"key":"3544_CR18","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s11920-023-01460-6","volume":"25","author":"BA Brand","year":"2023","unstructured":"Brand BA, Willemse EJM, Hamers IMH, Sommer IE. Evidence-based recommendations for the pharmacological treatment of women with schizophrenia spectrum disorders. Curr Psychiatry Rep. 2023;25:723\u201333.","journal-title":"Curr Psychiatry Rep"},{"key":"3544_CR19","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1176\/appi.ajp.20250111","volume":"183","author":"G Zhao","year":"2025","unstructured":"Zhao G, Sun Y, Zhang Y, Lu T, Lu Z, Kang Z, et al. Efficacy and tolerability of seven antipsychotic drugs in acutely ill patients with schizophrenia: a randomized, multicenter, assessor-blinded trial. Am J Psychiatry. 2025;183:112\u201323. appiajp20250111","journal-title":"Am J Psychiatry"},{"key":"3544_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-022-01825-0","volume":"12","author":"Z Lu","year":"2022","unstructured":"Lu Z, Zhang Y, Yan H, Su Y, Guo L, Liao Y, et al. ATAD3B and SKIL polymorphisms associated with antipsychotic-induced QTc interval change in patients with schizophrenia: a genome-wide association study. Transl Psychiatry. 2022;12:56.","journal-title":"Transl Psychiatry"},{"key":"3544_CR21","first-page":"53","volume":"38","author":"CD Society","year":"2018","unstructured":"Society CD. Chinese guideline for the prevention and treatment of type 2 diabetes mellitus(2017 edition). Chin J Diabetes Mellitus. 2018;38:53.","journal-title":"Chin J Diabetes Mellitus"},{"key":"3544_CR22","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1038\/ng.979","volume":"43","author":"WH Yue","year":"2011","unstructured":"Yue WH, Wang HF, Sun LD, Tang FL, Liu ZH, Zhang HX, et al. Genome-wide association study identifies a susceptibility locus for schizophrenia in Han Chinese at 11p11.2. Nat Genet. 2011;43:1228\u201331.","journal-title":"Nat Genet"},{"key":"3544_CR23","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/S2215-0366(18)30049-X","volume":"5","author":"H Yu","year":"2018","unstructured":"Yu H, Yan H, Wang L, Li J, Tan L, Deng W, et al. Five novel loci associated with antipsychotic treatment response in patients with schizophrenia: a genome-wide association study. Lancet Psychiatry. 2018;5:327\u201338.","journal-title":"Lancet Psychiatry"},{"key":"3544_CR24","doi-asserted-by":"publisher","first-page":"S90","DOI":"10.1093\/schbul\/sbv167","volume":"42","author":"S Leucht","year":"2016","unstructured":"Leucht S, Samara M, Heres S, Davis JM. Dose equivalents for antipsychotic drugs: the DDD method. Schizophr Bull. 2016;42:S90\u201394.","journal-title":"Schizophr Bull"},{"key":"3544_CR25","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S0140-6736(19)31135-3","volume":"394","author":"M Huhn","year":"2019","unstructured":"Huhn M, Nikolakopoulou A, Schneider-Thoma J, Krause M, Samara M, Peter N, et al. Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis. Lancet. 2019;394:939\u201351.","journal-title":"Lancet"},{"key":"3544_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01261-5","volume":"8","author":"K Watanabe","year":"2017","unstructured":"Watanabe K, Taskesen E, van Bochoven A, Posthuma D. Functional mapping and annotation of genetic associations with FUMA. Nat Commun. 2017;8:1826.","journal-title":"Nat Commun"},{"key":"3544_CR27","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1038\/s41588-024-01933-1","volume":"56","author":"S Park","year":"2024","unstructured":"Park S, Kim S, Kim B, Kim DS, Kim J, Ahn Y, et al. Multivariate genomic analysis of 5\u2009million people elucidates the genetic architecture of shared components of the metabolic syndrome. Nat Genet. 2024;56:2380\u201391.","journal-title":"Nat Genet"},{"key":"3544_CR28","doi-asserted-by":"publisher","first-page":"e1009218","DOI":"10.1371\/journal.pgen.1009218","volume":"16","author":"D Ray","year":"2020","unstructured":"Ray D, Chatterjee N. A powerful method for pleiotropic analysis under composite null hypothesis identifies novel shared loci between type 2 diabetes and prostate cancer. PLoS Genet. 2020;16:e1009218.","journal-title":"PLoS Genet"},{"key":"3544_CR29","doi-asserted-by":"publisher","first-page":"634.e631","DOI":"10.1016\/j.ajog.2024.06.050","volume":"231","author":"P Long","year":"2024","unstructured":"Long P, Tan H, Chen B, Wang L, Quan R, Hu Z, et al. Dissecting the shared genetic architecture between anti-M\u00fcllerian hormone and age at menopause based on genome-wide association study. Am J Obstet Gynecol. 2024;231:634.e631\u2013634.e611.","journal-title":"Am J Obstet Gynecol"},{"key":"3544_CR30","doi-asserted-by":"publisher","first-page":"e1004219","DOI":"10.1371\/journal.pcbi.1004219","volume":"11","author":"CA de Leeuw","year":"2015","unstructured":"de Leeuw CA, Mooij JM, Heskes T, Posthuma D. MAGMA: generalized gene-set analysis of GWAS data. PLoS Comput Biol. 2015;11:e1004219.","journal-title":"PLoS Comput Biol"},{"key":"3544_CR31","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/nrg.2016.29","volume":"17","author":"CA de Leeuw","year":"2016","unstructured":"de Leeuw CA, Neale BM, Heskes T, Posthuma D. The statistical properties of gene-set analysis. Nat Rev Genet. 2016;17:353\u201364.","journal-title":"Nat Rev Genet"},{"key":"3544_CR32","doi-asserted-by":"publisher","first-page":"D1179","DOI":"10.1093\/nar\/gkac821","volume":"51","author":"M Lu","year":"2023","unstructured":"Lu M, Zhang Y, Yang F, Mai J, Gao Q, Xu X, et al. TWAS atlas: a curated knowledgebase of transcriptome-wide association studies. Nucleic Acids Res. 2023;51:D1179\u2013d1187.","journal-title":"Nucleic Acids Res"},{"key":"3544_CR33","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/ng.3506","volume":"48","author":"A Gusev","year":"2016","unstructured":"Gusev A, Ko A, Shi H, Bhatia G, Chung W, Penninx BW, et al. Integrative approaches for large-scale transcriptome-wide association studies. Nat Genet. 2016;48:245\u201352.","journal-title":"Nat Genet"},{"key":"3544_CR34","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jclinepi.2022.01.011","volume":"145","author":"GFN Berkelmans","year":"2022","unstructured":"Berkelmans GFN, Read SH, Gudbj\u00f6rnsdottir S, Wild SH, Franzen S, van der Graaf Y, et al. Population median imputation was noninferior to complex approaches for imputing missing values in cardiovascular prediction models in clinical practice. J Clin Epidemiol. 2022;145:70\u201380.","journal-title":"J Clin Epidemiol"},{"key":"3544_CR35","doi-asserted-by":"publisher","DOI":"10.1093\/gigascience\/giz082","volume":"8","author":"SW Choi","year":"2019","unstructured":"Choi SW, O\u2019Reilly PF. PRSice-2: polygenic risk score software for biobank-scale data. GigaScience. 2019;8:giz082.","journal-title":"GigaScience"},{"key":"3544_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.xgen.2022.100197","volume":"2","author":"YA Feng","year":"2022","unstructured":"Feng YA, Chen CY, Chen TT, Kuo PH, Hsu YH, Yang HI, et al. Taiwan biobank: a rich biomedical research database of the Taiwanese population. Cell Genom. 2022;2:100197.","journal-title":"Cell Genom"},{"key":"3544_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-016-3173-5","volume":"17","author":"X Corso-D\u00edaz","year":"2016","unstructured":"Corso-D\u00edaz X, de Leeuw CN, Alonso V, Melchers D, Wong BK, Houtman R, et al. Co-activator candidate interactions for orphan nuclear receptor NR2E1. BMC Genomics. 2016;17:832.","journal-title":"BMC Genomics"},{"key":"3544_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2020.113386","volume":"293","author":"YY Wang","year":"2020","unstructured":"Wang YY, Hsu SH, Tsai HY, Cheng MC. Genetic analysis of the NR2E1 gene as a candidate gene of schizophrenia. Psychiatry Res. 2020;293:113386.","journal-title":"Psychiatry Res"},{"key":"3544_CR39","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.jdiacomp.2014.12.018","volume":"29","author":"L Sun","year":"2015","unstructured":"Sun L, Deng H, He L, Hu X, Huang Q, Xue J, et al. The relationship between NR2E1 and subclinical inflammation in newly diagnosed type 2 diabetic patients. J Diabetes Complications. 2015;29:589\u201394.","journal-title":"J Diabetes Complications"},{"key":"3544_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.119562","volume":"278","author":"G He","year":"2021","unstructured":"He G, Gu J, Wang H, Cheng S, Xiong Q, Ke M, et al. Nr2e1 deficiency aggravates insulin resistance and chronic inflammation of visceral adipose tissues in a diet-induced obese mice model. Life Sci. 2021;278:119562.","journal-title":"Life Sci"},{"key":"3544_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109503","volume":"120","author":"Q Xiong","year":"2019","unstructured":"Xiong Q, Wu Y, Yang M, Wu G, Wang Y, Wang H, et al. Nr2e1 ablation impairs liver glucolipid metabolism and induces inflammation, high-fat diets amplify the damage. Biomed Pharmacother. 2019;120:109503.","journal-title":"Biomed Pharmacother"},{"key":"3544_CR42","doi-asserted-by":"publisher","first-page":"4875","DOI":"10.1016\/j.apsb.2023.08.016","volume":"13","author":"W Yu","year":"2023","unstructured":"Yu W, Hu Y, Liu Z, Guo K, Ma D, Peng M, et al. Sorting nexin 3 exacerbates doxorubicin-induced cardiomyopathy via regulation of TFRC-dependent ferroptosis. Acta Pharm Sin B. 2023;13:4875\u201392.","journal-title":"Acta Pharm Sin B"},{"key":"3544_CR43","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.gep.2010.08.007","volume":"11","author":"R Mizutani","year":"2011","unstructured":"Mizutani R, Nakamura K, Yokoyama S, Sanbe A, Kusakawa S, Miyamoto Y, et al. Developmental expression of sorting nexin 3 in the mouse central nervous system. Gene Expr Patterns. 2011;11:33\u201340.","journal-title":"Gene Expr Patterns"},{"key":"3544_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s12920-015-0141-x","volume":"8","author":"G Homuth","year":"2015","unstructured":"Homuth G, Wahl S, M\u00fcller C, Schurmann C, M\u00e4der U, Blankenberg S, et al. Extensive alterations of the whole-blood transcriptome are associated with body mass index: results of an mRNA profiling study involving two large population-based cohorts. BMC Med Genomics. 2015;8:65.","journal-title":"BMC Med Genomics"},{"key":"3544_CR45","doi-asserted-by":"publisher","first-page":"3794","DOI":"10.2337\/db16-0470","volume":"65","author":"BH Chen","year":"2016","unstructured":"Chen BH, Hivert MF, Peters MJ, Pilling LC, Hogan JD, Pham LM, et al. Peripheral blood transcriptomic signatures of fasting glucose and insulin concentrations. Diabetes. 2016;65:3794\u2013804.","journal-title":"Diabetes"},{"key":"3544_CR46","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.1038\/s41418-021-00789-w","volume":"28","author":"J Lu","year":"2021","unstructured":"Lu J, Xu S, Huo Y, Sun D, Hu Y, Wang J, et al. Sorting nexin 3 induces heart failure via promoting retromer-dependent nuclear trafficking of STAT3. Cell Death Differ. 2021;28:2871\u201387.","journal-title":"Cell Death Differ"},{"key":"3544_CR47","doi-asserted-by":"publisher","first-page":"jcs219956","DOI":"10.1242\/jcs.219956","volume":"131","author":"EM Germany","year":"2018","unstructured":"Germany EM, Zahayko N, Huebsch ML, Fox JL, Prahlad V, Khalimonchuk O. The AAA ATPase Afg1 preserves mitochondrial fidelity and cellular health by maintaining mitochondrial matrix proteostasis. J Cell Sci. 2018;131:jcs219956.","journal-title":"J Cell Sci"},{"key":"3544_CR48","doi-asserted-by":"publisher","first-page":"7898","DOI":"10.3390\/ijms24097898","volume":"24","author":"SK Masenga","year":"2023","unstructured":"Masenga SK, Kabwe LS, Chakulya M, Kirabo A. Mechanisms of oxidative stress in metabolic syndrome. Int J Mol Sci. 2023;24:7898.","journal-title":"Int J Mol Sci"},{"key":"3544_CR49","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.lfs.2016.02.002","volume":"148","author":"V Rani","year":"2016","unstructured":"Rani V, Deep G, Singh RK, Palle K, Yadav UC. Oxidative stress and metabolic disorders: pathogenesis and therapeutic strategies. Life Sci. 2016;148:183\u201393.","journal-title":"Life Sci"},{"key":"3544_CR50","doi-asserted-by":"publisher","first-page":"3857","DOI":"10.1080\/10408398.2020.1809344","volume":"61","author":"J Yang","year":"2021","unstructured":"Yang J, Suo H, Song J. Protective role of mitoquinone against impaired mitochondrial homeostasis in metabolic syndrome. Crit Rev Food Sci Nutr. 2021;61:3857\u201375.","journal-title":"Crit Rev Food Sci Nutr"},{"key":"3544_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2024.116195","volume":"342","author":"C Pisanu","year":"2024","unstructured":"Pisanu C, Congiu D, Meloni A, Paribello P, Severino G, Ardau R, et al. Sex differences in shared genetic determinants between severe mental disorders and metabolic traits. Psychiatry Res. 2024;342:116195.","journal-title":"Psychiatry Res"},{"key":"3544_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2022.114738","volume":"316","author":"MV Seeman","year":"2022","unstructured":"Seeman MV. Sex\/gender differences in schizophrenia: thinking back and thinking forward. Psychiatry Res. 2022;316:114738.","journal-title":"Psychiatry Res"},{"key":"3544_CR53","first-page":"e190013","volume":"4","author":"LN Castellani","year":"2019","unstructured":"Castellani LN, Costa-Dookhan KA, McIntyre WB, Wright DC, Flowers SA, Hahn MK, et al. Preclinical and clinical sex differences in antipsychotic-induced metabolic disturbances: a narrative review of adiposity and glucose metabolism. J Psychiatr Brain Sci. 2019;4:e190013.","journal-title":"J Psychiatr Brain Sci"},{"key":"3544_CR54","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1136\/gutjnl-2020-323323","volume":"71","author":"S Smati","year":"2022","unstructured":"Smati S, Polizzi A, Fougerat A, Ellero-Simatos S, Blum Y, Lippi Y, et al. Integrative study of diet-induced mouse models of NAFLD identifies PPAR\u03b1 as a sexually dimorphic drug target. Gut. 2022;71:807\u201321.","journal-title":"Gut"},{"key":"3544_CR55","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s12017-020-08629-9","volume":"23","author":"AK Strosznajder","year":"2021","unstructured":"Strosznajder AK, W\u00f3jtowicz S, Je\u017cyna MJ, Sun GY, Strosznajder JB. Recent insights on the role of PPAR-\u03b2\/\u03b4 in neuroinflammation and neurodegeneration, and its potential target for therapy. Neuromolecular Med. 2021;23:86\u201398.","journal-title":"Neuromolecular Med"},{"key":"3544_CR56","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1016\/j.bbrc.2014.07.005","volume":"450","author":"AK S\u00e1rv\u00e1ri","year":"2014","unstructured":"S\u00e1rv\u00e1ri AK, Ver\u00e9b Z, Uray IP, F\u00e9s\u00fcs L, Balajthy Z. Atypical antipsychotics induce both proinflammatory and adipogenic gene expression in human adipocytes in vitro. Biochem Biophys Res Commun. 2014;450:1383\u20139.","journal-title":"Biochem Biophys Res Commun"},{"key":"3544_CR57","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.ejmech.2019.04.030","volume":"173","author":"A Ammazzalorso","year":"2019","unstructured":"Ammazzalorso A, Maccallini C, Amoia P, Amoroso R. Multitarget PPAR\u03b3 agonists as innovative modulators of the metabolic syndrome. Eur J Med Chem. 2019;173:261\u201373.","journal-title":"Eur J Med Chem"},{"key":"3544_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1074911","volume":"13","author":"Y Lin","year":"2022","unstructured":"Lin Y, Wang Y, Li PF. PPAR\u03b1: an emerging target of metabolic syndrome, neurodegenerative and cardiovascular diseases. Front Endocrinol (Lausanne). 2022;13:1074911.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3544_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.103130","volume":"62","author":"Y Wada","year":"2020","unstructured":"Wada Y, Maekawa M, Ohnishi T, Balan S, Matsuoka S, Iwamoto K, et al. Peroxisome proliferator-activated receptor \u03b1 as a novel therapeutic target for schizophrenia. EBioMedicine. 2020;62:103130.","journal-title":"EBioMedicine"},{"key":"3544_CR60","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1038\/s41380-024-02447-2","volume":"29","author":"Y Liao","year":"2024","unstructured":"Liao Y, Yu H, Zhang Y, Lu Z, Sun Y, Guo L, et al. Genome-wide association study implicates lipid pathway dysfunction in antipsychotic-induced weight gain: multi-ancestry validation. Mol Psychiatry. 2024;29:1857\u201368.","journal-title":"Mol Psychiatry"},{"key":"3544_CR61","first-page":"24","volume":"10","author":"LK Guo","year":"2023","unstructured":"Guo LK, Su Y, Zhang YY, Yu H, Lu Z, Li WQ, et al. Prediction of treatment response to antipsychotic drugs for precision medicine approach to schizophrenia: randomized trials and multiomics analysis. Mil Med Res. 2023;10:24.","journal-title":"Mil Med Res"},{"key":"3544_CR62","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.euroneuro.2023.01.001","volume":"69","author":"A Sathyanarayanan","year":"2023","unstructured":"Sathyanarayanan A, Mueller TT, Ali Moni M, Schueler K, Baune BT, Lio P, et al. Multi-omics data integration methods and their applications in psychiatric disorders. Eur Neuropsychopharmacol. 2023;69:26\u201346.","journal-title":"Eur Neuropsychopharmacol"},{"key":"3544_CR63","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ajp.2016.05.006","volume":"22","author":"S Ganesh","year":"2016","unstructured":"Ganesh S, Ashok AH, Kumar CN, Thirthalli J. Prevalence and determinants of metabolic syndrome in patients with schizophrenia: A systematic review and meta-analysis of Indian studies. Asian J Psychiatr. 2016;22:86\u201392.","journal-title":"Asian J Psychiatr"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03544-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03544-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03544-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T08:03:01Z","timestamp":1781510581000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03544-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,21]]},"references-count":63,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["3544"],"URL":"https:\/\/doi.org\/10.1038\/s41380-026-03544-0","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,21]]},"assertion":[{"value":"16 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All studies were approved by the institutional ethics review boards. The discovery cohort was approved by the ethics committees at each participating site, Peking University Sixth Hospital, West China Hospital of Sichuan University, the Second Xiangya Hospital of Central South University, Beijing Anding Hospital affiliated with Capital Medical University, and Beijing Huilongguan Hospital. The validation cohort was approved by the ethics committees of Peking University Sixth Hospital, Beijing Anding Hospital affiliated with Capital Medical University, the Second Xiangya Hospital of Central South University, Wuxi Mental Health Center, Shanghai Mental Health Center, Renmin Hospital of Wuhan University, Shandong Mental Health Center, Henan Mental Health Center, and Xiamen Xianyue Hospital. Written informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}]}}